CELC
Celcuity LLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.74B
P/E Ratio
—
EPS
$-3.89
Beta
0.09
52W High
$151.02
52W Low
$10.26
50-Day MA
$121.95
200-Day MA
$92.83
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Celcuity LLC
Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States. The company is headquartered in Minneapolis, Minnesota.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-186.39M |
| Operating Margin | 0.00% |
| Return on Equity | -275.20% |
| Return on Assets | -37.10% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.11 |
| Price-to-Book | 125.79 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -7.80 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $48.77M |
| Float | $26.81M |
| % Insiders | 10.01% |
| % Institutions | 101.22% |
Historical Volatility
HV 10-Day
66.95%
HV 20-Day
78.14%
HV 30-Day
72.96%
HV 60-Day
65.82%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($169.00 target)
2
Strong Buy9
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026